(BN) Brookfield - Ratings and Ratios

Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA11271J1075

BN: Real Estate, Infrastructure, Energy, Assets, Capital, Equity

Brookfield Corporation is a global leader in alternative asset management, specializing in real estate, renewable power, infrastructure, and private equity. With a strong focus on institutional-grade assets, the firm manages a diverse range of public and private investment vehicles, catering to both retail and institutional clients. Its investment strategy revolves around acquiring high-quality, large-scale assets across various geographies and sectors, leveraging both its own capital and that of external investors.

In the private equity and venture capital space, Brookfield adopts a multi-strategy approach, covering control buyouts, corporate carve-outs, recapitalizations, and investments in underperforming mid-market companies. The firm also engages in operational restructuring, capital structure optimization, and strategic re-direction of portfolio companies. Its private equity investments are concentrated in sectors with significant underlying real assets, such as industrial products, building materials, metals, mining, and manufacturing. This focus on tangible assets provides a layer of stability and downside protection.

Geographically, Brookfield operates across North America (including the U.S., Canada, and Brazil), Europe, Australia, and the Asia-Pacific region. The firm’s equity investments typically range from $2 million to $500 million, with a four-year investment period and a 10-year fund term, extendable by two years. Brookfield prefers to take both minority and majority stakes, depending on the opportunity, allowing it to tailor its involvement to the specific needs of each portfolio company.

Founded in 1997 and headquartered in Toronto, Canada, Brookfield Corporation has established a robust global presence, with offices spanning North America, South America, Europe, the Middle East, and Asia. This extensive network enables the firm to identify and execute on attractive investment opportunities worldwide. For investors and fund managers, Brookfield’s diversified approach, long-term investment horizon, and focus on real assets make it

Additional Sources for BN Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

BN Stock Overview

Market Cap in USD 85,855m
Sector Financial Services
Industry Asset Management
GiC Sub-Industry Asset Management & Custody Banks
IPO / Inception

BN Stock Ratings

Growth 5y 68.2%
Fundamental -11.6%
Dividend 33.7%
Rel. Strength Industry 12.5
Analysts -
Fair Price Momentum 80.51 CAD
Fair Price DCF -

BN Dividends

Dividend Yield 12m 0.44%
Yield on Cost 5y 0.73%
Annual Growth 5y 6.90%
Payout Consistency 27.3%

BN Growth Ratios

Growth Correlation 3m 8.8%
Growth Correlation 12m 94.8%
Growth Correlation 5y 65.2%
CAGR 5y 14.87%
CAGR/Max DD 5y 0.39
Sharpe Ratio 12m 1.34
Alpha 20.77
Beta 1.36
Volatility 27.78%
Current Volume 2267k
Average Volume 20d 1504.3k
What is the price of BN stocks?
As of March 06, 2025, the stock is trading at CAD 79.24 with a total of 2,267,000 shares traded.
Over the past week, the price has changed by -4.21%, over one month by -7.16%, over three months by -5.85% and over the past year by +42.00%.
Is Brookfield a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Brookfield is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -11.63 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BN as of March 2025 is 80.51. This means that BN is currently overvalued and has a potential downside of 1.6%.
Is BN a buy, sell or hold?
Brookfield has no consensus analysts rating.
What are the forecast for BN stock price target?
According to ValueRays Forecast Model, BN Brookfield will be worth about 88.3 in March 2026. The stock is currently trading at 79.24. This means that the stock has a potential upside of +11.48%.
Issuer Forecast Upside
Wallstreet Target Price 75.7 -4.5%
Analysts Target Price - -
ValueRay Target Price 88.3 11.5%